Biogen
BIIB
BIIB
1,089 hedge funds and large institutions have $35.6B invested in Biogen in 2021 Q1 according to their latest regulatory filings, with 140 funds opening new positions, 357 increasing their positions, 406 reducing their positions, and 99 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,089
Holders Change
+33
Holders Change %
+3.13%
% of All Funds
19.18%
Holding in Top 10
13
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+85.71%
% of All Funds
0.23%
New
140
Increased
357
Reduced
406
Closed
99
Calls
$1.45B
Puts
$1.37B
Net Calls
+$74.1M
Net Calls Change
-$267M
Top Buyers
| 1 |
JPMorgan Chase & Co
New York
|
+$273M |
| 2 |
Primecap Management
Pasadena,
California
|
+$262M |
| 3 |
SAM
Southeastern Asset Management
Memphis,
Tennessee
|
+$169M |
| 4 |
ClearBridge Investments
New York
|
+$104M |
| 5 |
A
AustralianSuper
Melbourne,
Australia
|
+$103M |
Top Sellers
| 1 |
Renaissance Technologies
New York
|
-$308M |
| 2 |
O
OrbiMed
New York
|
-$125M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$117M |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$100M |
| 5 |
State Street
Boston,
Massachusetts
|
-$89.4M |
